John Douglas Markman

John Douglas Markman spearheads initiatives to address the complexities of neuropathic pain as a distinguished neurosurgeon and professor at the University of Rochester. With a profound commitment to advancing the field of pain management, he leads the Translational Pain Research Program, where his innovative approaches have significantly contributed to understanding and treating neuropathic pain. As the vice chair for clinical research in the Department of Neurosurgery, Dr. Markman plays a pivotal role in bridging the gap between clinical practice and research, fostering a collaborative environment that encourages groundbreaking discoveries. Dr. Markman's research endeavors have earned him numerous accolades, including the prestigious Mitchel Max Scientific Award for Neuropathic Pain Research from the American Academy of Neurology. His dedication to excellence in pain management has also been recognized by the American Pain Society, which honored him with the Clinical Centers of Excellence in Pain Management Award. These awards underscore his commitment to improving patient outcomes and advancing the science of pain management. In addition to his research and clinical work, Dr. Markman is a prolific author, having contributed to over 87 journal articles and 12 books on topics related to pain management. His publications serve as valuable resources for both clinicians and researchers, offering insights into the latest advancements and methodologies in the field. Through his scholarly contributions, Dr. Markman continues to influence the next generation of neurosurgeons and pain specialists, inspiring them to pursue innovative solutions to complex medical challenges. Dr. Markman's dedication to his field is matched by his passion for education and mentorship. He is deeply committed to training future leaders in neurosurgery and pain management, providing them with the knowledge and skills necessary to excel in their careers. His leadership and expertise have made a lasting impact on the University of Rochester and the broader medical community, solidifying his reputation as a leading figure in the study and treatment of neuropathic pain.